Advanced Filters
noise

Neoplasms Clinical Trials

A listing of Neoplasms medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 14,180 clinical trials
Y Yesmine Amara (principal investigator), PhD student

Distraction With Virtual Reality From Pain and Anxiety for Patients With Hematological Malignancies

The goal of this clinical trial] is to study the effectiveness of Virtual Reality (VR) in reducing pain and anxiety during painful procedures for patients with hematological malignancies The main question[s] it aims to answer are: Does VR effectively reduce pain during painful procedures for patients with hematological malignancies ? …

6 years of age All Phase N/A

A Study of JMT203 in Patients With Cancer Cachexia

This is an open-label, multicenter Phase I clinical study aimed at evaluating the safety/tolerability, pharmacokinetics, and effectiveness of JMT203 in patients with cancer cachexia.

18 years of age All Phase 1
P Philippe PR Richebé, MD, PhD

Thoracic Paravertebral Block Anesthesia for Breast Cancer Surgery

Background Mastectomies are traditionally performed under general anesthesia (GA), often with the addition of regional anesthesia for post-operative pain relief. Thoracic paravertebral blocks (TPVB) had previously been described in the literature to be sufficient for intra-operative anesthesia as an alternative to GA. A 2021 literature review by Cochrane Library comparing …

18 years of age Female Phase N/A
M Melissa Fridstein

Selumetinib and Azacitidine in High Risk Chronic Blood Cancers

This is a phase I, open-label, dose-escalation study to determine the MTD of selumetinib when combined with the standard dose of azacitidine. Treatment will begin within 28 days of screening procedures. Treatment will continue indefinitely, provided that the patient continues to derive benefit. A patient will be taken off study …

18 years of age All Phase 1

Treatment Recommendations for Gastrointestinal Cancers Via Large Language Models

This study will evaluate the utility of ChatGPT in recommending treatment plans for patients with gastrointestinal cancers, using both retrospective and prospective data.

18 years of age All Phase N/A
J Jinxin Lin, PhD,MD

Tubeless NOSES Versus Laparoscopic Radical Resection for Rectosigmoid Cancers

This study is designed to evaluate the short-term and long-term results after Tubeless NOSES for the resection of Rectosigmoid Cancers compared with traditional laparoscopic radical resection.

18 - 75 years of age All Phase N/A

EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers

This study is to evaluate the safety and antitumor activity of EMB-01 in advanced/metastatic gastrointestinal cancers, including gastric cancer, hepatocellular cancer, cholangiocarcinoma and colorectal cancer.

18 years of age All Phase 1/2
H Hewitt Chang

Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers

This phase II trial studies how well radiation therapy works for the treatment of gastrointestinal cancer that are spreading to other places in the body (metastatic). Radiation therapy uses high energy x-rays to kill cancer cells and shrink tumors. This trial is being done to determine if giving radiation therapy …

18 years of age All Phase N/A
C Clinical Trial Referral Office

HEADLIGHT: Hypofractionated Proton Therapy for Head and Neck Cancers

This clinical trial tests whether intensity modulated proton therapy after surgery works to shrink tumors in patients with head and neck cancer. Radiation therapy uses high energy protons to kill tumor cells and shrink tumors.

18 years of age All Phase 2
L Liwei Chen

Nutritional Psychological Intervention and Vomit-free Management on Survival and Quality of Life in Advanced Gastrointestinal Tumors

Aims to observe and evaluate the impact of survival and quality of life of patients with gastrointestinal tumors such as advanced esophageal, gastric, liver, pancreatic, and colorectal cancers through nutritional-psychological interventions versus no-vomit management compared to standard antitumor therapy alone

18 - 75 years of age All Phase N/A

Simplify language using AI